Rockefeller Capital Management
ARKG icon

Rockefeller Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Rockefeller Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2M Buy
99,958
+68,191
+215% +$2.17M 0.01% 1049
2026
Q1 		$839K Buy
31,767
+7,524
+31% +$220K ﹤0.01% 1696
2025
Q4 		$702K Buy
24,243
+461
+2% +$13.8K ﹤0.01% 1723
2025
Q3 		$660K Buy
+23,782
New +$601K ﹤0.01% 1628
2025
Q1 		– Sell
-12,150
Closed -$286K – 1660
2024
Q4 		$286K Buy
12,150
+1,439
+13% +$35.4K ﹤0.01% 1603
2024
Q3 		$274K Sell
10,711
-1,139
-10% -$29K ﹤0.01% 1554
2024
Q2 		$278K Sell
11,850
-2,135
-15% -$53.9K ﹤0.01% 1564
2024
Q1 		$402K Sell
13,985
-6,273
-31% -$189K ﹤0.01% 1528
2023
Q4 		$665K Buy
20,258
+2,584
+15% +$70.3K ﹤0.01% 1268
2023
Q3 		$492K Buy
17,674
+2,341
+15% +$76.5K ﹤0.01% 1290
2023
Q2 		$523K Sell
15,333
-1,306
-8% -$41K ﹤0.01% 1325
2023
Q1 		$500K Sell
16,639
-534
-3% -$16.5K ﹤0.01% 1353
2022
Q4 		$484K Sell
17,173
-334,991
-95% -$10.6M ﹤0.01% 1297
2022
Q3 		$11.6M Buy
352,164
+39,386
+13% +$1.45M 0.06% 321
2022
Q2 		$9.85M Buy
312,778
+296,251
+1,793% +$10.4M 0.05% 352
2022
Q1 		$758K Buy
16,527
+3,817
+30% +$182K ﹤0.01% 1157
2021
Q4 		$777K Sell
12,710
-2,104
-14% -$145K ﹤0.01% 1144
2021
Q3 		$1.11M Buy
14,814
+455
+3% +$38.2K 0.01% 966
2021
Q2 		$1.33M Sell
14,359
-2,649
-16% -$225K 0.01% 828
2021
Q1 		$1.51M Buy
17,008
+5,471
+47% +$543K 0.01% 658
2020
Q4 		$1.07M Buy
11,537
+4,248
+58% +$338K 0.01% 675
2020
Q3 		$464K Buy
+7,289
New +$427K ﹤0.01% 812

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Rockefeller Capital Management's ARKG Position: Q2 2026 in Review

Rockefeller Capital Management increased its ARK Genomic Revolution ETF (ARKG) stake by 215% in Q2 2026, buying an estimated $2.17M and bringing the position to 99,958 shares worth $4.2M. The position accounts for 0.01% of the portfolio, ranked #1049.

Rockefeller Capital Management first reported a position in ARKG in Q3 2020 and has held it in 22 quarters since. The position peaked at $11.6M in Q3 2022. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Rockefeller Capital Management held 99,958 shares of ARK Genomic Revolution ETF worth $4.2M as of Q2 2026.
  • Rockefeller Capital Management bought 68,191 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.17M.
  • ARK Genomic Revolution ETF made up 0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1049 holding.
  • Rockefeller Capital Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 22 quarters since.
  • Rockefeller Capital Management's ARK Genomic Revolution ETF position peaked at $11.6M in Q3 2022.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.